Trial intelligence / Profile preview

Fermented Soy Extract in Localized Prostate Cancer

NCT03532308Phase 3Terminated

Sponsor
Yale University
Start
Nov 2018
Primary completion
Dec 2019
Countries
1
01

Overview

Phase 3, randomised, double-blind trial (2 arms), sponsored by Yale University. Primary endpoint: Prostate-specific Antigen. Started Nov 2018; status: terminated.

Beyond the preview

Go deeper on NCT03532308.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03532308.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call